Knockout studies of ADCK2 in prostate and osteosarcoma cells have demonstrated a reduced impact of tumor necrosis factor-alpha (TNFα) on hypoxia-inducible factor 1-alpha (HIF-1α), suggesting a potential role for ADCK2 in hypoxia-driven tumor progression. This evidence concerns the gene HIF1A and osteosarcoma.